secwatch / observer
8-K filed November 7, 2023, 6:59 PM ET ticker LXEO CIK 0001907108
other material confidence high sentiment neutral materiality 0.10

Lexeo Therapeutics amends charter and bylaws upon IPO closing on Nov 7, 2023

Lexeo Therapeutics, Inc.

item 5.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Lexeo Therapeutics, Inc.: Filed amended and restated certificate of incorporation effective as of immediately prior to the closing of the IPO.

Change
charter amendment
Exact text from the filing
the Company filed an amended and restated certificate of incorporation (the “ Restated Certificate ”) with the Secretary of State of the State of Delaware.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Lexeo Therapeutics, Inc.: Adopted amended and restated bylaws effective upon the closing of the IPO (effective 2023-11-07).

Change
bylaw amendment
Effective
2023-11-07
Exact text from the filing
the Company adopted amended and restated bylaws (the “ Restated Bylaws ”) in connection with the closing of the IPO.
View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Lexeo Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-272430
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.